Dr. Schwarz received her bachelor's degree in biology from Scripps College, her MAT in biology from Northwestern University and her medical degree from Washington University in St. Louis, Missouri. She then completed her residency in Pediatrics and fellowship in Pediatric Gastroenterology at St. Louis Children's Hospital, Washington University School of Medicine. She has been triply boarded by the American Board of Pediatrics in Pediatrics, Pediatric Gastroenterology and Pediatric Transplant Hepatology. She was Chief of Pediatric Gastroenterology at St.

Physician Assistant practicing general hepatology at academic, liver transplant center as of 2001.

I received my MD at Russian University of Friendship, Moscow. I then studied biochemistry and immunology during my graduate studies at Christian-Albrecht University, Germany. As a postdoctoral fellow at Columbia University (USA), I studied signal transduction, and expanded my skills in transgenic mouse technologies. I joined UCSD as a principal investigator. The major interest of my research is the identification of new targets for the therapy of MASH and MetALD-associated liver fibrosis and cholestatic fibrosis.

Dr. Yasuko Iwakiri is a Professor of Medicine at Yale School of Medicine, specializing in liver fibrosis, cirrhosis, and portal hypertension, with a focus on the vascular system, including lymphatics and liver endothelial cells. Her research also investigates endothelial-immune cell interactions, particularly macrophages, in alcohol-associated liver disease. She currently serves as an Associate Editor for the Journal of Hepatology and has previously held editorial roles with Hepatology and Hepatology Communications.

Dr. Nidhi Jalan-Sakrikar, Ph.D., is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, with a joint appointment in the Department of Biochemistry & Molecular Biology. She leads an independent research program focused on immune-mediated mechanisms that drive inflammation and fibrosis in PSC, a chronic cholestatic liver disease characterized by progressive bile duct injury.

Consultant hepatologist at Hospital Clinic Barcelona, Associate professor at University of Barcelona

Dr. Craig Lammert is an Associate Professor of Medicine at Indiana University and an adult hepatologist specializing in autoimmune liver diseases, with a particular focus on autoimmune hepatitis (AIH). His clinical and translational research program centers on advancing the understanding of AIH through studies involving genetics, biomarkers, autoantibodies, and high-dimensional proteomic platforms. He is an active clinical investigator dedicated to improving therapeutic development and clinical trial design in AIH.

Imran Hasanoglu is an Associate Professor of Infectious Diseases and Clinical Microbiology at Ankara Yildirim Beyazit University School of Medicine, Turkiye, and the lead infectious diseases physician for the kidney transplant unit at Ankara Bilkent City Hospital.

Dr. Yao-Chun (Holden) Hsu is currently Professor of Medicine at I-Shou University, and also the Director of the Department of Medical Research at E-Da Hospital in Kaohsiung, Taiwan. Beyond his dedication to front-line patient care, Dr. Hsu is committed to clinical and translational research in liver diseases, emphasizing viral hepatitis, with a special focus on chronic hepatitis B. He spearheads the hepatitis B research team at E-Da Hospital and fosters collaborations with researchers globally.

Dr. Nguyen is Professor of Medicine, a Stanford Cancer Institute member and specializes in the treatment and prevention of primary liver cancer such as hepatocellular carcinoma (HCC).